Click for best price
Paronychia Drugs Market Size, Share 2022
Paronychia usually happens when the skin around an individual's nail is irritated or harmed. Paronychia is a soft tissue infection of the skin around the fingernails and toenails. Bacteria which cause this type of infection are known as Candida. The infection begins as cellulitis but may progress to a definite abscess.
This report contains market size and forecasts of Paronychia Drugs in Global, including the following market information:
Global Paronychia Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Paronychia Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Mupirocin Ointment Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Paronychia Drugs include GlaxoSmithKline, Teva Pharmaceutical, Eli Lilly, Fougera Pharmaceuticals, Taro Pharmaceutical Industries, Glenmark Generics and Jonakayem Pharma Formulation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Paronychia Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Paronychia Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Paronychia Drugs Market Segment Percentages, by Type, 2021 (%)
Mupirocin Ointment
Fusidic Acid Ointment
Gentamicin Ointment
Dicloxacillin
Others
Global Paronychia Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Paronychia Drugs Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Dermatology Center
Others
Global Paronychia Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Paronychia Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Paronychia Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Paronychia Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Teva Pharmaceutical
Eli Lilly
Fougera Pharmaceuticals
Taro Pharmaceutical Industries
Glenmark Generics
Jonakayem Pharma Formulation
| Report Attributes |
Report Details |
| Report Title |
Paronychia Drugs Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
62 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Paronychia Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Paronychia Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Paronychia Drugs Overall Market Size
2.1 Global Paronychia Drugs Market Size: 2021 VS 2028
2.2 Global Paronychia Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Paronychia Drugs Players in Global Market
3.2 Top Global Paronychia Drugs Companies Ranked by Revenue
3.3 Global Paronychia Drugs Revenue by Companies
3.4 Top 3 and Top 5 Paronychia Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Paronychia Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Paronychia Drugs Players in Global Market
3.6.1 List of Global Tier 1 Paronychia Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Paronychia Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Paronychia Drugs Market Size Markets, 2021 & 2028
4.1.2 Mupirocin Ointment
4.1.3 Fusidic Acid Ointment
4.1.4 Gentamicin Ointment
4.1.5 Dicloxacillin
4.1.6 Others
4.2 By Type - Global Paronychia Drugs Revenue & Forecasts
4.2.1 By Type - Global Paronychia Drugs Revenue, 2017-2022
4.2.2 By Type - Global Paronychia Drugs Revenue, 2023-2028
4.2.3 By Type - Global Paronychia Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Paronychia Drugs Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Dermatology Center
5.1.5 Others
5.2 By Application - Global Paronychia Drugs Revenue & Forecasts
5.2.1 By Application - Global Paronychia Drugs Revenue, 2017-2022
5.2.2 By Application - Global Paronychia Drugs Revenue, 2023-2028
5.2.3 By Application - Global Paronychia Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Paronychia Drugs Market Size, 2021 & 2028
6.2 By Region - Global Paronychia Drugs Revenue & Forecasts
6.2.1 By Region - Global Paronychia Drugs Revenue, 2017-2022
6.2.2 By Region - Global Paronychia Drugs Revenue, 2023-2028
6.2.3 By Region - Global Paronychia Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Paronychia Drugs Revenue, 2017-2028
6.3.2 US Paronychia Drugs Market Size, 2017-2028
6.3.3 Canada Paronychia Drugs Market Size, 2017-2028
6.3.4 Mexico Paronychia Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Paronychia Drugs Revenue, 2017-2028
6.4.2 Germany Paronychia Drugs Market Size, 2017-2028
6.4.3 France Paronychia Drugs Market Size, 2017-2028
6.4.4 U.K. Paronychia Drugs Market Size, 2017-2028
6.4.5 Italy Paronychia Drugs Market Size, 2017-2028
6.4.6 Russia Paronychia Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Paronychia Drugs Market Size, 2017-2028
6.4.8 Benelux Paronychia Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Paronychia Drugs Revenue, 2017-2028
6.5.2 China Paronychia Drugs Market Size, 2017-2028
6.5.3 Japan Paronychia Drugs Market Size, 2017-2028
6.5.4 South Korea Paronychia Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Paronychia Drugs Market Size, 2017-2028
6.5.6 India Paronychia Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Paronychia Drugs Revenue, 2017-2028
6.6.2 Brazil Paronychia Drugs Market Size, 2017-2028
6.6.3 Argentina Paronychia Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Paronychia Drugs Revenue, 2017-2028
6.7.2 Turkey Paronychia Drugs Market Size, 2017-2028
6.7.3 Israel Paronychia Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Paronychia Drugs Market Size, 2017-2028
6.7.5 UAE Paronychia Drugs Market Size, 2017-2028
7 Players Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Corporate Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Paronychia Drugs Major Product Offerings
7.1.4 GlaxoSmithKline Paronychia Drugs Revenue in Global Market (2017-2022)
7.1.5 GlaxoSmithKline Key News
7.2 Teva Pharmaceutical
7.2.1 Teva Pharmaceutical Corporate Summary
7.2.2 Teva Pharmaceutical Business Overview
7.2.3 Teva Pharmaceutical Paronychia Drugs Major Product Offerings
7.2.4 Teva Pharmaceutical Paronychia Drugs Revenue in Global Market (2017-2022)
7.2.5 Teva Pharmaceutical Key News
7.3 Eli Lilly
7.3.1 Eli Lilly Corporate Summary
7.3.2 Eli Lilly Business Overview
7.3.3 Eli Lilly Paronychia Drugs Major Product Offerings
7.3.4 Eli Lilly Paronychia Drugs Revenue in Global Market (2017-2022)
7.3.5 Eli Lilly Key News
7.4 Fougera Pharmaceuticals
7.4.1 Fougera Pharmaceuticals Corporate Summary
7.4.2 Fougera Pharmaceuticals Business Overview
7.4.3 Fougera Pharmaceuticals Paronychia Drugs Major Product Offerings
7.4.4 Fougera Pharmaceuticals Paronychia Drugs Revenue in Global Market (2017-2022)
7.4.5 Fougera Pharmaceuticals Key News
7.5 Taro Pharmaceutical Industries
7.5.1 Taro Pharmaceutical Industries Corporate Summary
7.5.2 Taro Pharmaceutical Industries Business Overview
7.5.3 Taro Pharmaceutical Industries Paronychia Drugs Major Product Offerings
7.5.4 Taro Pharmaceutical Industries Paronychia Drugs Revenue in Global Market (2017-2022)
7.5.5 Taro Pharmaceutical Industries Key News
7.6 Glenmark Generics
7.6.1 Glenmark Generics Corporate Summary
7.6.2 Glenmark Generics Business Overview
7.6.3 Glenmark Generics Paronychia Drugs Major Product Offerings
7.6.4 Glenmark Generics Paronychia Drugs Revenue in Global Market (2017-2022)
7.6.5 Glenmark Generics Key News
7.7 Jonakayem Pharma Formulation
7.7.1 Jonakayem Pharma Formulation Corporate Summary
7.7.2 Jonakayem Pharma Formulation Business Overview
7.7.3 Jonakayem Pharma Formulation Paronychia Drugs Major Product Offerings
7.7.4 Jonakayem Pharma Formulation Paronychia Drugs Revenue in Global Market (2017-2022)
7.7.5 Jonakayem Pharma Formulation Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Paronychia Drugs Market Opportunities & Trends in Global Market
Table 2. Paronychia Drugs Market Drivers in Global Market
Table 3. Paronychia Drugs Market Restraints in Global Market
Table 4. Key Players of Paronychia Drugs in Global Market
Table 5. Top Paronychia Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Paronychia Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Paronychia Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Paronychia Drugs Product Type
Table 9. List of Global Tier 1 Paronychia Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Paronychia Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Paronychia Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Paronychia Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Paronychia Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Paronychia Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Paronychia Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Paronychia Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Paronychia Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Paronychia Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Paronychia Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Paronychia Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Paronychia Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Paronychia Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Paronychia Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Paronychia Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Paronychia Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Paronychia Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Paronychia Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Paronychia Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Paronychia Drugs Revenue, (US$, Mn), 2023-2028
Table 30. GlaxoSmithKline Corporate Summary
Table 31. GlaxoSmithKline Paronychia Drugs Product Offerings
Table 32. GlaxoSmithKline Paronychia Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Teva Pharmaceutical Corporate Summary
Table 34. Teva Pharmaceutical Paronychia Drugs Product Offerings
Table 35. Teva Pharmaceutical Paronychia Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Eli Lilly Corporate Summary
Table 37. Eli Lilly Paronychia Drugs Product Offerings
Table 38. Eli Lilly Paronychia Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Fougera Pharmaceuticals Corporate Summary
Table 40. Fougera Pharmaceuticals Paronychia Drugs Product Offerings
Table 41. Fougera Pharmaceuticals Paronychia Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Taro Pharmaceutical Industries Corporate Summary
Table 43. Taro Pharmaceutical Industries Paronychia Drugs Product Offerings
Table 44. Taro Pharmaceutical Industries Paronychia Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Glenmark Generics Corporate Summary
Table 46. Glenmark Generics Paronychia Drugs Product Offerings
Table 47. Glenmark Generics Paronychia Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Jonakayem Pharma Formulation Corporate Summary
Table 49. Jonakayem Pharma Formulation Paronychia Drugs Product Offerings
Table 50. Jonakayem Pharma Formulation Paronychia Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Paronychia Drugs Segment by Type in 2021
Figure 2. Paronychia Drugs Segment by Application in 2021
Figure 3. Global Paronychia Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Paronychia Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Paronychia Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Paronychia Drugs Revenue in 2021
Figure 8. By Type - Global Paronychia Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Paronychia Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Paronychia Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Paronychia Drugs Revenue Market Share, 2017-2028
Figure 12. US Paronychia Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Paronychia Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Paronychia Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Paronychia Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Paronychia Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Paronychia Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Paronychia Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Paronychia Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Paronychia Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Paronychia Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Paronychia Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Paronychia Drugs Revenue Market Share, 2017-2028
Figure 24. China Paronychia Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Paronychia Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Paronychia Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Paronychia Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Paronychia Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Paronychia Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Paronychia Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Paronychia Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Paronychia Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Paronychia Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Paronychia Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Paronychia Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Paronychia Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. GlaxoSmithKline Paronychia Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Teva Pharmaceutical Paronychia Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Eli Lilly Paronychia Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Fougera Pharmaceuticals Paronychia Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Taro Pharmaceutical Industries Paronychia Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Glenmark Generics Paronychia Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Jonakayem Pharma Formulation Paronychia Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
